Technology
New On Robinhood
Health

Urovant Sciences

$11.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.27 (2.45%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell UROV and other stocks, options, ETFs, and crypto commission-free!

About

Urovant Sciences Ltd. Common Stock, also called Urovant Sciences, is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of innovative therapies for urologic conditions. Read More Its pipeline includes Vibegron (RVT-901) and Overactive Bladder (OAB). The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.

Employees
โ€”
Headquarters
London, Greater London
Founded
โ€”
Market Cap
341.74M
Price-Earnings Ratio
โ€”
Dividend Yield
โ€”
Average Volume
107.22K
High Today
$11.35
Low Today
$10.52
Open Price
$11.01
Volume
118.23K
52 Week High
$14.49
52 Week Low
$4.06

Collections

Technology
New On Robinhood
Health
Pharmaceutical
Medical
Biopharmaceutical
2018 IPO
UK

News

MarketWatchMar 15

Urovant Sciences Ltd.

Thereโ€™s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Urovant Sciences Ltd (UROV) and ...[...] on SmarterAnalyst...

168

Earnings

-$1.23
-$1.08
-$0.92
-$0.77
Q2 2018
Q3 2018
Q4 2018
Estimated
โ€”
Actual
Expected May 19, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.